On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayAug 02, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Steadily Achieving Its Operational and Business Plan Objectives

Lexaria just completed dosing for its second human clinical study, HYPER-H21-2  The study sought to understand the human response to Lexaria’s DehydraTECH 2.0-enabled CBD The company also announced that its DehydraTECH-enabled consumer products are available for purchase in over 7,000 stores across the United States Lexaria also expanded its intellectual property portfolio with the allowance of its second patent in Japan It also received US$3,817,643 from warrant exercises, proceeds from which will be used to advance the company’s research and development program and for its general corporate purposes Lexaria Bioscience (NASDAQ: LEXX) has been making incredible strides in 2021 as…

Continue Reading

FridayJul 30, 2021 10:59 am

Emaginos Inc. Offers Investors Potential to Solve Problems, See Return on Investment

Emaginos is committed to solving two major education problems Investing in Emaginos provides an opportunity to do good and do well, says company president Company plans to transform America’s public schools to a more effective model based on a carefully integrated set of proven best practices Emaginos, a company raising new capital under provisions of Regulation A of the Securities Act of 1933 (please see website if interested in investing), is seeking $3 million to begin the transformation of the K-12 education system in the United States. Based on the company’s proprietary Discover Learning System (“DLS”), Emaginos offers investors an…

Continue Reading

FridayJul 30, 2021 10:30 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Launches Second Stage of Manufacturing of Ibogaine for Clinical Research

The company has filed patent applications for two routes of chemical synthesis of ibogaine – offering potential advantages of improved isomeric purity, chiral purity, and easily isolated intermediate compounds Preliminary data indicates that the drug shows promise as a treatment for neuropathic pain and migraines, as well as the treatment of addiction The company is positioned to engage several markets, including digital therapeutics and research Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (“MINDCURE”), a diversified life sciences company at the forefront of the mental health industry, recently announced the launch of its second manufacturing stage of pharmaceutical-grade ibogaine to be…

Continue Reading

FridayJul 30, 2021 10:02 am

Brain Scientific Inc. (BRSF) Poised to Benefit as Rapidly Growing Brain-Computer Interface Field Drives EEG Growth

Brain-Computer Interface (“BCI”) market is expanding rapidly, expected to double to USD 406 billion by 2026 BCI technology, designed to acquire brain signals, analyze and translate them into commands, is one of key driving forces behind EEG technology growth Brain Scientific appears poised to capitalize on this novel technology as its applications expand from medical settings to training, consumer engagement, entertainment, and more The Brain-Computer Interface (“BCI”) field is growing rapidly, representing one of the main driving factors behind the expansion of EEG technology. As the provider of EEG technology, Brain Scientific (OTCQB: BRSF) appears well placed to leverage this…

Continue Reading

FridayJul 30, 2021 9:40 am

FingerMotion Inc.’s (FNGR) SMS & MMS, Telecommunications Products & Services, and Big Data Businesses Continue To Soar

FingerMotion’s SMS & MMS, TPS, and Big Data divisions generated $6.00 million in revenue for Q1 2022 The SMS & MMS and TPS businesses’ Q1 2022 revenues increased significantly compared to Q1 2021 figures Q1 2022 also marked the second consecutive quarter in which the big data division generated revenue, and a Q/Q increase at that FingerMotion is also targeting the accretive rich communications services (“RCS”) segment, with RCS expected to form its fourth division On July 15, evolving technology company FingerMotion (OTCQX: FNGR) released its Q1 2022 results in which it reported record quarterly revenue of $6.00 million, generated…

Continue Reading

FridayJul 30, 2021 9:30 am

Golden Triangle Ventures Inc. (GTVH) Announces Armageddon Event, First-Ever Production of Its Kind

Epic stage production features a unique end-of-the-world theme Company is curating a theme to create a ground-breaking production With more than 30,000 national followers, EpicRaves is on its way to achieving goal of becoming nationally recognized concert production company Golden Triangle Ventures (OTC: GTVH) is making company history with the announcement of its debut event series: Armageddon (https://ibn.fm/5vKmz). This epic stage production features a unique end-of-the-world theme and is the company’s first-ever offering of this kind.  “We will deploy the largest Hennessy Sound Design system Las Vegas has ever seen in history for this amazing event, and we are going…

Continue Reading

FridayJul 30, 2021 9:00 am

Sustainable Green Team Ltd. (SGTM) Subsidiary Ideally Positioned to Offer Expertise, Crucial Services During Above-Average Hurricane Season

NOAA predicts above-average 2021 storm season SGTM wholly owned subsidiary provides unparalleled services, including commercial property storm recovery, tree trimming, clean up Company’s management team deploys its mobile command center, strategized with national partners to provide much-needed services The National Oceanic and Atmospheric Administration (“NOAA”) Climate Prediction Center is anticipating an above-normal Atlantic hurricane season in the coming months (https://ibn.fm/GNdk1). NOAA forecasters are predicting a 60% chance of an above-normal season, a 30% chance of a near-normal season, and a 10% chance of a below-normal season. The Sustainable Green Team (OTC: SGTM) and its wholly owned subsidiary National Storm Recovery…

Continue Reading

FridayJul 30, 2021 9:00 am

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) CEO to Present at Two Upcoming Conferences

Nextech Founder and CEO Evan Gappelberg will present at the OTCQB Venture Virtual Investor Conference, scheduled for August 5, 2021, and later at the Jefferies Software Conference to be held September 14 to 15, 2021 Earlier this year, Evan presented at a Virtual Investor Conference, wherein he highlighted the company’s plans, some of which it has already implemented Thus, during the upcoming conferences, which will bring together companies and investors, attendees can expect to learn more about Nextech, its core business, expectations, and more Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF), one of the leaders in the rapidly growing augmented…

Continue Reading

FridayJul 30, 2021 9:00 am

Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Reports Record Q2 2021 Revenues

Company executed record quarter by focusing on profitable operations, accretive acquisition of Homegrown Oregon Chalice posts record quarterly revenue, gross profit numbers Homegrown chain of five stores joined the Chalice brand earlier this year Chalice Brands (CSE: CHAL) (OTCQB: CHALF) has released its 2021 second-quarter unaudited financial, noting highest-ever quarterly revenues, along with other promising numbers (https://ibn.fm/JETHJ). The company is a premier consumer-driven company specializing in the retail, production, processing, wholesale and distribution of cannabis. “We are immensely proud to execute another record quarter by focusing on profitable operations and the accretive acquisition of Homegrown Oregon,” stated Chalice CEO and…

Continue Reading

ThursdayJul 29, 2021 9:30 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Proprietary Imaging System Set to Advance Bladder Cancer Visualization

Approximatively 75-85% of patients with confirmed cases of bladder cancer are diagnosed with non-muscle invasive (“NMIBC”) Imagin Medical’s innovative technology is targeting this type of bladder cancer and set to be completed in 2022  Blue light cystoscopy helps surgeons visualize the cancerous cells that are not detected by white light, enabling an improved resection Non-muscle-invasive bladder cancer (“NMIBC”) is a type of bladder cancer that has not infiltrated the other muscle tissues inside the bladder or spread to the lymph nodes. Approximately 75-85% of patients presenting with bladder cancer are diagnosed with NMIBC. The most common symptoms of NMIBC which…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered